These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22936968)

  • 1. Screen anti-influenza lead compounds that target the PA(C) subunit of H5N1 viral RNA polymerase.
    Li L; Chang S; Xiang J; Li Q; Liang H; Tang Y; Liu Y
    PLoS One; 2012; 7(8):e35234. PubMed ID: 22936968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: Molecular dynamics simulation and MM-GBSA calculation.
    Jin Z; Wang Y; Yu XF; Tan QQ; Liang SS; Li T; Zhang H; Shaw PC; Wang J; Hu C
    Comput Biol Chem; 2020 Apr; 85():107241. PubMed ID: 32120300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins.
    Bortz E; Westera L; Maamary J; Steel J; Albrecht RA; Manicassamy B; Chase G; Martínez-Sobrido L; Schwemmle M; García-Sastre A
    mBio; 2011; 2(4):. PubMed ID: 21846828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal region of the PA subunit of the RNA polymerase of influenza A/HongKong/156/97 (H5N1) influences promoter binding.
    Kashiwagi T; Leung BW; Deng T; Chen H; Brownlee GG
    PLoS One; 2009; 4(5):e5473. PubMed ID: 19421324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus.
    He X; Zhou J; Bartlam M; Zhang R; Ma J; Lou Z; Li X; Li J; Joachimiak A; Zeng Z; Ge R; Rao Z; Liu Y
    Nature; 2008 Aug; 454(7208):1123-6. PubMed ID: 18615018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.
    Byrn RA; Jones SM; Bennett HB; Bral C; Clark MP; Jacobs MD; Kwong AD; Ledeboer MW; Leeman JR; McNeil CF; Murcko MA; Nezami A; Perola E; Rijnbrand R; Saxena K; Tsai AW; Zhou Y; Charifson PS
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1569-82. PubMed ID: 25547360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention.
    De Clercq E; Neyts J
    Trends Pharmacol Sci; 2007 Jun; 28(6):280-5. PubMed ID: 17481739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fight against the influenza A virus H1N1: synthesis, molecular modeling, and biological evaluation of benzofurazan derivatives as viral RNA polymerase inhibitors.
    Pagano M; Castagnolo D; Bernardini M; Fallacara AL; Laurenzana I; Deodato D; Kessler U; Pilger B; Stergiou L; Strunze S; Tintori C; Botta M
    ChemMedChem; 2014 Jan; 9(1):129-50. PubMed ID: 24285596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of susceptibility variants of influenza virus grown in the presence of T-705.
    Daikoku T; Yoshida Y; Okuda T; Shiraki K
    J Pharmacol Sci; 2014; 126(3):281-4. PubMed ID: 25296868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling.
    Trist IM; Nannetti G; Tintori C; Fallacara AL; Deodato D; Mercorelli B; Palù G; Wijtmans M; Gospodova T; Edink E; Verheij M; de Esch I; Viteva L; Loregian A; Botta M
    J Med Chem; 2016 Mar; 59(6):2688-703. PubMed ID: 26924568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PA Mutations Inherited during Viral Evolution Act Cooperatively To Increase Replication of Contemporary H5N1 Influenza Virus with an Expanded Host Range.
    Arai Y; Kawashita N; Elgendy EM; Ibrahim MS; Daidoji T; Ono T; Takagi T; Nakaya T; Matsumoto K; Watanabe Y
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33028722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor.
    Xiong H; Foulk M; Aschenbrenner L; Fan J; Tiong-Yip CL; Johnson KD; Moustakas D; Fleming PR; Brown DG; Zhang M; Ferguson D; Wu D; Yu Q
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6789-93. PubMed ID: 24211022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PA from an H5N1 highly pathogenic avian influenza virus activates viral transcription and replication and induces apoptosis and interferon expression at an early stage of infection.
    Wang Q; Zhang S; Jiang H; Wang J; Weng L; Mao Y; Sekiguchi S; Yasui F; Kohara M; Buchy P; Deubel V; Xu K; Sun B; Toyoda T
    Virol J; 2012 Jun; 9():106. PubMed ID: 22681768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding mechanism of H5N1 influenza virus neuraminidase with ligands and its implication for drug design.
    Gong K; Li L; Wang JF; Cheng F; Wei DQ; Chou KC
    Med Chem; 2009 May; 5(3):242-9. PubMed ID: 19442214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.
    Chintakrindi AS; Martis EA; Gohil DJ; Kothari ST; Chowdhary AS; Coutinho EC; Kanyalkar MA
    Curr Comput Aided Drug Des; 2016; 12(4):272-281. PubMed ID: 27412704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase.
    Yuan S; Chu H; Singh K; Zhao H; Zhang K; Kao RY; Chow BK; Zhou J; Zheng BJ
    Sci Rep; 2016 Mar; 6():22880. PubMed ID: 26956222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Influenza Virus (H5N1) Activity Screening on the Phloroglucinols from Rhizomes of Dryopteris crassirhizoma.
    Wang J; Yan YT; Fu SZ; Peng B; Bao LL; Zhang YL; Hu JH; Zeng ZP; Geng DH; Gao ZP
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28282885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.
    Vanderlinden E; Vrancken B; Van Houdt J; Rajwanshi VK; Gillemot S; Andrei G; Lemey P; Naesens L
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6679-6691. PubMed ID: 27572398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
    Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
    Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
    Rungrotmongkol T; Frecer V; De-Eknamkul W; Hannongbua S; Miertus S
    Antiviral Res; 2009 Apr; 82(1):51-8. PubMed ID: 19428595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.